Elstar Therapeutics
Manufacturing · Michigan, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3827 W Grand St, Detroit, Michigan, 4823...Phone Number
(617) 917-4980Website
www.elstartherapeutics.comRevenue
$16.2 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Elstar Therapeutics
Elstar Therapeutics is fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating antibody-based, multi-functional therapeutics. Armed with a unique approach to engaging multiple immune mechanisms, Elstar enables patients to harness their own body to fight cancer. Elstar's Universal Targeted Immunotherapy (UniTI) platform is positioned to overcome barriers that are limiting the full potential of other promising immunotherapeutic approaches. "Our motivation...to be part of the cure for cancer."Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elstar Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Elstar Therapeutics launches new products
Check out if Elstar Therapeutics is spiking on competitors!
Check if Elstar Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Elstar Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Elstar Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Elstar Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Elstar Therapeutics
Click to see if Elstar Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Elstar Therapeutics
Find 3 more new buyers
Compare Similar Companies to Elstar Therapeutics
Compare insights from companies similar to Elstar Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Elstar Therapeutics
$16.2M
11-50
Private
$39M
2015
N/A
Company Profile Activity
Activity Insights
Elstar Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Elstar Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Elstar Therapeutics.
Elstar Therapeutics financials insights
Gather financial insights about Elstar Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$39M
Elstar Therapeutics Tech Stack
A closer look at the technologies used by Elstar Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Elstar Therapeutics News & Media
Elstar Therapeutics locks in $39 mln Series A
Cambridge, Massachusetts-based Elstar Therapeutics, a provider of precision cancer immunotherapy, has raised $39 million in Series A financing. The investor was Apple Tree Partners.Elstar Therapeutics Closes $39M Series A Financing
Elstar Therapeutics, a Cambridge, Mass.-based precision cancer immunotherapy company, closed a $39M Series A financing. Founding backer Apple Tree Partners made the investment. The funds will be used to expand its growing pipeline and progress several early stage molecules towards the clinic. Led by Steve Arkinstall, D.Phil., President and Chief Executive Officer, Andreas Loew, Ph.D., […]Elstar Therapeutics Closes $39M Series A
CAMBRIDGE, MA, Elstar Therapeutics announced the closing of a $39M Series A financing round by founding investor Apple Tree Partners.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Elstar Therapeutics
Sign Up For FreeTo access detailed company insights
Elstar Therapeutics is fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating antibody-based, multi-functional therapeutics. Armed with a unique approach to engaging multiple immune mechanisms, Elstar enables patients to harness their own body to fight cancer. Elstar's Universal Targeted Immunotherapy... Read More
